Palmar plantar erythrodysesthesia physical examination: Difference between revisions
Line 53: | Line 53: | ||
===Neuromuscular=== | ===Neuromuscular=== | ||
* Neuromuscular examination of patients with palmar plantar erythrodysesthesia is usually normal. | * Neuromuscular examination of patients with palmar plantar erythrodysesthesia is usually normal. Rarely, sensory impairment in the extemities may be seen. <ref name="pmid11034047">{{cite journal| author=Hui YF, Cortes JE| title=Palmar-plantar erythrodysesthesia syndrome associated with liposomal daunorubicin. | journal=Pharmacotherapy | year= 2000 | volume= 20 | issue= 10 | pages= 1221-3 | pmid=11034047 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11034047 }} </ref> <ref name="urlwww.oncologynurseadvisor.com">{{cite web |url=https://www.oncologynurseadvisor.com/home/departments/ce-courses/prevention-and-management-of-hand-foot-syndromes/ |title=www.oncologynurseadvisor.com |format= |work= |accessdate=}}</ref> | ||
==References== | ==References== |
Revision as of 15:50, 12 July 2019
Palmar plantar erythrodysesthesia Microchapters |
Differentiating Palmar plantar erythrodysesthesia from other Diseases |
---|
Diagnosis |
Treatment |
Palmar plantar erythrodysesthesia physical examination On the Web |
American Roentgen Ray Society Images of Palmar plantar erythrodysesthesia physical examination |
FDA on Palmar plantar erythrodysesthesia physical examination |
CDC on Palmar plantar erythrodysesthesia physical examination |
Palmar plantar erythrodysesthesia physical examination in the news |
Blogs on Palmar plantar erythrodysesthesia physical examination |
Directions to Hospitals Treating Palmar plantar erythrodysesthesia |
Risk calculators and risk factors for Palmar plantar erythrodysesthesia physical examination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mandana Chitsazan, M.D. [2]
Overview
Physical examination of patients with palmar plantar erythrodysesthesia depends on the grade of the disease. Determination of toxicity grading of PPE requires both visual assessment and patient description of symptoms. Skin findings include erythema, edema, hyperkeratosis, peeling, blisters, bleedings, and fissures.
Physical Examination
Physical examination of patients with palmar plantar erythrodysesthesia depends on the grade of the disease. Determination of toxicity grading of PPE requires both visual assessment and patient description of symptoms.
Appearance of the Patient
- Patients with palmar plantar erythrodysesthesia usually appear normal.
Vital Signs
- Vital signs are normal.
Skin
- Skin examination of patients with palmar plantar erythrodysesthesia depends on the grade of the disease. Determination of toxicity grading of PPE requires both visual assessment and patient description of symptoms.
- Physical findings include:[1]
- Erythema
- Edema
- Hyperkeratosis
- Peeling
- Blisters
- Bleeding
- Fissures
HEENT
- HEENT examination of patients with palmar plantar erythrodysesthesia is usually normal.
Neck
- Neck examination of patients with palmar plantar erythrodysesthesia is usually normal.
Lungs
- Pulmonary examination of patients with palmar plantar erythrodysesthesia is usually normal.
Heart
- Cardiovascular examination of patients with palmar plantar erythrodysesthesia is usually normal.
Abdomen
- Abdominal examination of patients with palmar plantar erythrodysesthesia is usually normal.
Back
- Back examination of patients with palmar plantar erythrodysesthesia is usually normal.
Genitourinary
- Genitourinary examination of patients with palmar plantar erythrodysesthesia is usually normal.
Neuromuscular
- Neuromuscular examination of patients with palmar plantar erythrodysesthesia is usually normal. Rarely, sensory impairment in the extemities may be seen. [2] [3]
References
- ↑ "Protocol Development | CTEP".
- ↑ Hui YF, Cortes JE (2000). "Palmar-plantar erythrodysesthesia syndrome associated with liposomal daunorubicin". Pharmacotherapy. 20 (10): 1221–3. PMID 11034047.
- ↑ "www.oncologynurseadvisor.com".